Bindolent 25 mg Powder for concentrate for solution for infusion Vial 5pcs

Product Overview

Bindolent 25 mg Powder for concentrate for solution for infusion is a specialized medication designed for intravenous administration, primarily used in clinical settings such as Intensive Care Units (ICUs).

As a potent alpha-2 adrenergic agonist, Bindolent offers sedative, anxiolytic, and analgesic properties, making it valuable for managing sedation in critically ill, mechanically ventilated adult patients.

It is presented as a powder which requires reconstitution and further dilution before being administered as a continuous intravenous infusion by healthcare professionals.

This product is critical for providing controlled and manageable sedation, allowing patients to remain calm and cooperative during their recovery process while minimizing respiratory depression.

Benefits of Use

• Provides sedation for critically ill patients in the Intensive Care Unit (ICU).
• Aids in reducing anxiety and provides mild analgesia without significant respiratory depression.
• Facilitates a state of conscious sedation, allowing patients to be easily aroused and communicate.
• Often preferred for long-term sedation due to its specific pharmacological profile.
• Can reduce the need for opioid analgesics in some cases.

How to Use

Bindolent must be administered by healthcare professionals trained in the management of patients requiring intensive care.

1. Inspect the vial for any visible particles or discoloration before reconstitution.
2. Reconstitute the powder according to the manufacturer's instructions using a suitable diluent.
3. Further dilute the reconstituted solution to achieve the desired concentration for infusion.
4. Administer Bindolent as a continuous intravenous infusion using a controlled infusion pump.
5. Dosage must be individualized and titrated to achieve the desired level of sedation, based on the patient's response and clinical condition.
6. Continuous monitoring of vital signs, including heart rate, blood pressure, and oxygen saturation, is essential throughout the infusion.

Caution & Warnings

• Bindolent is for intravenous use only and should not be administered as a rapid bolus injection due to the potential for severe hypotension and bradycardia.
• Close monitoring of cardiac function and blood pressure is required, especially during the loading dose and dose adjustments.
• May cause bradycardia (slow heart rate) and hypotension (low blood pressure); exercise caution in patients with pre-existing cardiac conditions.
• Avoid abrupt discontinuation of Bindolent after prolonged use, as this may lead to withdrawal reactions.
• Should be used with caution in patients with severe hepatic impairment, as dose adjustments may be necessary.
• Not recommended for use in pediatric patients younger than 18 years of age due to insufficient data on safety and efficacy.
• Pregnancy and breastfeeding: Use only if the potential benefit justifies the potential risk to the fetus or infant.

Ingredients

• Active Ingredient: Dexmedetomidine hydrochloride
• Strength: 25 mg per vial (as powder for concentrate)

Product Details

• Form: Powder for concentrate for solution for infusion
• Administration Route: Intravenous
• Pack Size: 5 Vials
• Legal Status: Prescription Only Medicine
• Storage: Store below 25°C, protect from light. Do not freeze.